SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Mazzarella who wrote (2459)4/19/1997 12:04:00 AM
From: WWS   of 4342
 
Richard, I can't help but think that Babish must have tried repeatedly to peddle the various "promising candidates" that his in vitro signal transduction methodology uncovered. But neither majors nor minors signed up to partner, possibly because their own researchers uncover hundreds more promising candidates than they can ever explore. And PRLN never had the resources to take more than a couple of candidates past this very preliminary stage. Even for those two, A.Car and A.Vir, no one stepped forward to partner. Apparently, whatever PRLN added to the existing knowledge base of these extracts was not highly valued by the biotech and pharmaceutical firms that constitute PRLN's primary market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News